Jane Street »

Sonnet Biotherapeutc Hldng I shares owned by Jane Street

Quarter-by-quarter ownership of Sonnet Biotherapeutc Hldng I (SONN) shares owned by Jane Street from 13F filings

Historical chart of Jane Street investment in Sonnet Biotherapeutc Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Sonnet Biotherapeutc Hldng I held by Jane Street consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sonnet Biotherapeutc Hldng I by Jane Street

Quarter filed Position value Share count Share price at filing
2025-09-30 $48k 11k 4.58

More positions owned by Jane Street

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Spdr Gold Tr Gold Shs (GLD)
Apple Call Option (AAPL)
Taiwan Semiconductor Mfg Sponsored Ads Put Option (TSM)
Microsoft Corporation Call Option (MSFT)
Advanced Micro Devices Call Option (AMD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Strategy Cl A New (MSTR)
Broadcom Call Option (AVGO)
Amazon Call Option (AMZN)

View all positions for Jane Street

Top funds holding Sonnet Biotherapeutc Hldng I

Ikarian Capital
Vanguard Group
Hrt Financial
Geode Capital Management
Boothbay Fund Management
Goldman Sachs Group
Citadel Advisors
Virtu Financial
State Street Corporation
BlackRock
Northern Trust
Two Sigma Investments
Investment House
Jane Street
Jpmorgan Chase & Co

View all funds holding Sonnet Biotherapeutc Hldng I